Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Black pepper leaf extract contains compounds that can block testosterone effects and promote hair growth.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Dutasteride is more effective than finasteride for hair loss treatment.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Compounds from the plant Mammea siamensis may help treat hair loss.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

High TNF-α levels may increase hair loss risk after PRP therapy.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.